ClinicalTrials.Veeva

Menu

Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer

Memorial Sloan Kettering Cancer Center (MSK) logo

Memorial Sloan Kettering Cancer Center (MSK)

Status

Completed

Conditions

Endometrial Cancer
Lymphedema

Treatments

Behavioral: questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT02912767
16-1001

Details and patient eligibility

About

The investigators are interested in understanding how the patient has been doing since their surgery for endometrial cancer and if they are experiencing any symptoms related to lymphedema (swelling) in the your lower body. The investigators hope that information from the patient and others will help them improve care for women treated for endometrial cancer.

Enrollment

625 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presented to MSK with newly diagnosed endometrial carcinoma of any histologic profile clinically confined to the uterus and/or uterine cervix
  • Underwent primary surgery at our institution, to include at least a total hysterectomy via laparotomy, laparoscopy, or robotic approach, between January 2006 and December 2013
  • Alive at the time of study activation

Exclusion criteria

  • Had documented macroscopic evidence of extrauterine disease at the time of initial diagnosis

Trial design

625 participants in 2 patient groups

SLN cohort
Description:
Patients who underwent hysterectomy only or with SLN mapping alone.
Treatment:
Behavioral: questionnaire
LND cohort
Description:
Patients who underwent hysterectomy with standard lymphadenectomy, with or without SLN mapping.
Treatment:
Behavioral: questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems